- Home
- OKUR vs LGL Comparison
OKUR vs LGL Comparison
Compare OKUR & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKUR
- LGL
- Stock Information
- Founded
- OKUR 2011
- LGL 1917
- Country
- OKUR United States
- LGL United States
- Employees
- OKUR N/A
- LGL N/A
- Industry
- OKUR
- LGL Industrial Machinery/Components
- Sector
- OKUR
- LGL Technology
- Exchange
- OKUR NYSE
- LGL Nasdaq
- Market Cap
- OKUR 34.9M
- LGL 38.5M
- IPO Year
- OKUR N/A
- LGL N/A
- Fundamental
- Price
- OKUR $2.52
- LGL $7.66
- Analyst Decision
- OKUR Strong Buy
- LGL
- Analyst Count
- OKUR 4
- LGL 0
- Target Price
- OKUR $32.25
- LGL N/A
- AVG Volume (30 Days)
- OKUR 69.8K
- LGL 47.6K
- Earning Date
- OKUR 08-14-2025
- LGL 08-12-2025
- Dividend Yield
- OKUR N/A
- LGL N/A
- EPS Growth
- OKUR N/A
- LGL 204.51
- EPS
- OKUR N/A
- LGL 0.08
- Revenue
- OKUR N/A
- LGL $4,322,000.00
- Revenue This Year
- OKUR N/A
- LGL N/A
- Revenue Next Year
- OKUR N/A
- LGL N/A
- P/E Ratio
- OKUR N/A
- LGL $98.07
- Revenue Growth
- OKUR N/A
- LGL 20.66
- 52 Week Low
- OKUR $1.70
- LGL $5.03
- 52 Week High
- OKUR $20.00
- LGL $9.74
- Technical
- Relative Strength Index (RSI)
- OKUR N/A
- LGL 58.34
- Support Level
- OKUR N/A
- LGL $6.89
- Resistance Level
- OKUR N/A
- LGL $7.78
- Average True Range (ATR)
- OKUR 0.00
- LGL 1.06
- MACD
- OKUR 0.00
- LGL 0.03
- Stochastic Oscillator
- OKUR 0.00
- LGL 39.90
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.